Sandra L. Cook

Glatiramer acetate (Copaxone®) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis

Petra W. Duda, M. Schmied, Sandra L. Cook et al. · Journal of Clinical Investigation · 2000 · 418 citations · Full text

Sensitization to epithelial antigens in chronic mucosal inflammatory disease. I. Purification, characterization, and immune reactivity of murine epithelial cell-associated components (ECAC).

Ronnie Aronson, Sandra L. Cook, James K. Roche · The Journal of Immunology · 1983 · 39 citations

I. Purification, Immunology, Gastroenterology +23

Three‐year Open Protocol Continuation Study of Oral Tolerization with Myelin Antigens in Multiple Sclerosis and Design of a Phase III Pivotal Trial

Marika Hohol, Samia J. Khoury, Sandra L. Cook et al. · Annals of the New York Academy of Sciences · 1996 · 31 citations

Neurological Disorder, Medicine, Immunology +9

Treatment satisfaction across injectable, infusion, and oral disease-modifying therapies for multiple sclerosis

Tessa Eagle, Fiona Stuart, Alicia S. Chua et al. · Multiple Sclerosis and Related Disorders · 2017 · 17 citations

Neurological Disorder, Clinical Trials, Therapeutic Controversy +9

Patient-reported outcomes in multiple sclerosis: Relationships among existing scales and the development of a brief measure

Alicia S. Chua, Bonnie I. Glanz, A. J. Guarino et al. · Multiple Sclerosis and Related Disorders · 2015 · 10 citations

Reliability, Patient-reported Outcomes, Neurological Disorder +8